RAC 0.63% $1.59 race oncology ltd

CPACS: Research, Results, Market Comparisons, and Valuations, page-132

  1. 19,342 Posts.
    lightbulb Created with Sketch. 6437
    I am absolutely flat out at the moment and I haven’t had the chance to watch Mason’s presentation yet. I am not sure if I will be able to get to it before the weekend.

    I can say just from looking at the reference list that Mason has put in a ridiculous amount of work summarising all the scientific background to bisantrene and CPACS. We are extremely lucky to have investors like Mason willing to put in this amount of effort into research and be willing to share it freely.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.